file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 7398, GCS 21737, CR 38784 Collection span: 1977 - 2012 | |
| Word(i) List (2518) Word count: 12056, All words count: 16977 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | CHIMERIC | 13 | 104 | 173 |
| 202 | MODEL | 28 | 24 | 173 |
| 203 | REVIEW | 11 | 60 | 172 |
| 204 | VASCULARIZED | 10 | 12 | 172 |
| 205 | DECADES | 5 | 4 | 171 |
| 206 | FETAL-MATERNAL | 18 | 126 | 171 |
| 207 | ANTIGEN-SPECIFIC | 7 | 65 | 170 |
| 208 | APPROACH | 7 | 45 | 170 |
| 209 | ARTHRITIS | 18 | 74 | 170 |
| 210 | ANTI-CD4 | 4 | 55 | 169 |
| 211 | THYROIDITIS | 7 | 132 | 169 |
| 212 | JUVENILE | 10 | 123 | 167 |
| 213 | PHENOTYPE | 6 | 53 | 167 |
| 214 | CLONAL | 3 | 51 | 166 |
| 215 | PLACENTA | 5 | 34 | 165 |
| 216 | FETOMATERNAL | 11 | 106 | 164 |
| 217 | NOVEL | 7 | 50 | 164 |
| 218 | UNRESPONSIVENESS | 4 | 46 | 164 |
| 219 | OFFSPRING | 10 | 78 | 162 |
| 220 | GENDER | 8 | 25 | 161 |
| 221 | PRESUMED | 1 | 117 | 160 |
| 222 | SPECIMENS | 1 | 117 | 160 |
| 223 | GAUCHERS-DISEASE | 1 | 41 | 159 |
| 224 | GLYCOGEN-STORAGE-DISEASE | 1 | 41 | 159 |
| 225 | IMMUNE | 29 | 25 | 159 |
| 226 | TYPE-1 | 1 | 41 | 159 |
| 227 | TYPE-IV | 1 | 41 | 159 |
| 228 | NONINHERITED | 10 | 66 | 158 |
| 229 | INJURY | 9 | 99 | 156 |
| 230 | PROSPECTIVE | 12 | 46 | 156 |
| # | Word | Recs | TLCS | TGCS |
| 231 | FREQUENT | 1 | 86 | 155 |
| 232 | IMMUNOMODULATION | 4 | 2 | 155 |
| 233 | DERIVED | 8 | 42 | 154 |
| 234 | MULTIPLE | 19 | 98 | 154 |
| 235 | CELL-FREE | 5 | 55 | 152 |
| 236 | HEPATIC | 6 | 38 | 152 |
| 237 | HASHIMOTO | 5 | 127 | 151 |
| 238 | HEMATOLYMPHOID | 3 | 49 | 151 |
| 239 | IMMUNOLOGICAL | 16 | 15 | 151 |
| 240 | ESSENTIAL | 3 | 22 | 150 |
| 241 | TRANSFUSION-ASSOCIATED | 14 | 31 | 150 |
| 242 | SAMPLES | 6 | 18 | 148 |
| 243 | FUNCTION | 11 | 43 | 147 |
| 244 | EFFECTS | 12 | 14 | 146 |
| 245 | AUTOLOGOUS | 5 | 0 | 145 |
| 246 | MIXED | 10 | 22 | 145 |
| 247 | RHEUMATOID | 15 | 61 | 144 |
| 248 | HLA-HAPLOIDENTICAL | 16 | 60 | 143 |
| 249 | PLASMA | 5 | 10 | 143 |
| 250 | RESPONSES | 8 | 9 | 143 |
| 251 | ORTHOTOPIC | 6 | 22 | 141 |
| 252 | PULMONARY | 4 | 16 | 141 |
| 253 | SJOGREN | 16 | 110 | 141 |
| 254 | TRIAL | 3 | 4 | 141 |
| 255 | MYOPATHIES | 5 | 80 | 139 |
| 256 | RETROVIRUSES | 4 | 12 | 139 |
| 257 | ANERGY | 1 | 42 | 138 |
| 258 | PROMOTE | 2 | 28 | 138 |
| 259 | RENAL-TRANSPLANT | 1 | 42 | 138 |
| 260 | T-LYMPHOCYTE | 1 | 42 | 138 |
| # | Word | Recs | TLCS | TGCS |
| 261 | MONKEYS | 3 | 27 | 137 |
| 262 | PROLONGED | 5 | 14 | 137 |
| 263 | BASED | 18 | 79 | 136 |
| 264 | EXPRESS | 5 | 23 | 136 |
| 265 | HISTORY | 4 | 79 | 135 |
| 266 | REACTIONS | 4 | 45 | 135 |
| 267 | IMMUNITY | 13 | 30 | 134 |
| 268 | MULTILINEAGE | 2 | 97 | 134 |
| 269 | INFECTION | 8 | 13 | 133 |
| 270 | SIGNIFICANT | 3 | 115 | 132 |
| 271 | ACUTE | 20 | 32 | 131 |
| 272 | FIRST | 2 | 1 | 131 |
| 273 | HLA-DQA1 | 6 | 91 | 131 |
| 274 | IDIOPATHIC | 5 | 84 | 131 |
| 275 | NEONATAL | 10 | 59 | 131 |
| 276 | COMORBIDITIES | 1 | 5 | 130 |
| 277 | CONTROLLED | 1 | 5 | 130 |
| 278 | ERYTHEMATOSUS | 14 | 106 | 130 |
| 279 | FACE | 1 | 1 | 130 |
| 280 | INTERVIEW-BASED | 1 | 5 | 130 |
| 281 | LACK | 8 | 48 | 130 |
| 282 | MONTHS | 1 | 1 | 130 |
| 283 | PARTIAL | 1 | 1 | 130 |
| 284 | PERSISTENCE | 12 | 49 | 130 |
| 285 | FISH | 6 | 53 | 129 |
| 286 | HEALTH | 6 | 80 | 129 |
| 287 | HEPATITIS | 5 | 62 | 129 |
| 288 | QUANTIFICATION | 8 | 95 | 129 |
| 289 | IMMUNOLOGY | 8 | 20 | 128 |
| 290 | POSSIBLE | 7 | 55 | 128 |
| # | Word | Recs | TLCS | TGCS |
| 291 | CLASS | 10 | 36 | 127 |
| 292 | FACTOR | 7 | 36 | 127 |
| 293 | CURRENT | 3 | 15 | 126 |
| 294 | RELEVANCE | 8 | 47 | 126 |
| 295 | DEFINING | 1 | 12 | 125 |
| 296 | PROCEDURE | 3 | 0 | 125 |
| 297 | PERSPECTIVE | 4 | 8 | 124 |
| 298 | GRAFT-REJECTION | 1 | 78 | 122 |
| 299 | REAL-TIME | 18 | 88 | 122 |
| 300 | CORRELATIONS | 4 | 93 | 121 |
| 301 | INOCULATION | 7 | 13 | 121 |
| 302 | MORTALITY | 2 | 1 | 121 |
| 303 | GVH | 1 | 45 | 120 |
| 304 | LEGACY | 5 | 69 | 120 |
| 305 | NATURAL | 9 | 52 | 120 |
| 306 | ISLET | 11 | 54 | 119 |
| 307 | KINETICS | 5 | 47 | 118 |
| 308 | ENVIRONMENT | 3 | 9 | 117 |
| 309 | TRANSPLANTS | 9 | 13 | 117 |
| 310 | ANTIBODIES | 11 | 5 | 116 |
| 311 | POST-BONE | 2 | 4 | 116 |
| 312 | TRANSFUSIONS | 8 | 27 | 116 |
| 313 | STEM-CELL | 3 | 2 | 115 |
| 314 | MAINTENANCE | 6 | 37 | 114 |
| 315 | SITES | 2 | 69 | 114 |
| 316 | GENETICALLY | 3 | 2 | 113 |
| 317 | HA-1 | 4 | 22 | 113 |
| 318 | TISSUES | 12 | 61 | 113 |
| 319 | CADAVERIC-KIDNEY | 1 | 78 | 112 |
| 320 | QUANTITATION | 6 | 8 | 111 |
| # | Word | Recs | TLCS | TGCS |
| 321 | TOLEROGENIC | 1 | 28 | 111 |
| 322 | FLUORESCENT | 5 | 11 | 110 |
| 323 | FRONTIER | 2 | 62 | 110 |
| 324 | CIRCULATING | 5 | 78 | 109 |
| 325 | MIGRATION | 11 | 19 | 109 |
| 326 | MALIGNANCIES | 9 | 50 | 108 |
| 327 | FOUND | 3 | 12 | 107 |
| 328 | INDUCE | 7 | 28 | 107 |
| 329 | LYMPHOCYTE | 21 | 12 | 107 |
| 330 | PREVENTION | 6 | 5 | 107 |
| 331 | HEMORRHAGE | 2 | 55 | 106 |
| 332 | HIGH | 11 | 45 | 106 |
| 333 | PCR | 33 | 51 | 106 |
| 334 | DIABETES | 11 | 65 | 105 |
| 335 | ENDOTHELIAL | 8 | 34 | 105 |
| 336 | NORMAL | 10 | 76 | 105 |
| 337 | RATS | 19 | 65 | 105 |
| 338 | HOST | 6 | 10 | 104 |
| 339 | IMMUNOTHERAPY | 4 | 17 | 104 |
| 340 | INFLUENCE | 11 | 69 | 104 |
| 341 | LIGAND | 4 | 7 | 104 |
| 342 | POPULATION | 8 | 64 | 104 |
| 343 | XENOTRANSPLANTED | 2 | 8 | 104 |
| 344 | IMMATURE | 5 | 6 | 103 |
| 345 | ALLELES | 14 | 47 | 102 |
| 346 | PRESENT | 3 | 50 | 102 |
| 347 | BREAST | 11 | 53 | 101 |
| 348 | MECHANISM | 4 | 17 | 101 |
| 349 | PERV | 9 | 7 | 101 |
| 350 | REACTIVITY | 7 | 11 | 101 |
| # | Word | Recs | TLCS | TGCS |
| 351 | ANSWER | 1 | 77 | 100 |
| 352 | FETUS | 11 | 45 | 100 |
| 353 | HISTORICAL | 2 | 8 | 100 |
| 354 | INVESTIGATIVE | 1 | 57 | 100 |
| 355 | SARCOMA | 2 | 7 | 100 |
| 356 | GREEN | 3 | 5 | 99 |
| 357 | TRANSPLANTED | 9 | 7 | 99 |
| 358 | IMMUNOMODULATORY | 4 | 14 | 98 |
| 359 | INTRATHYROIDAL | 3 | 81 | 98 |
| 360 | LYMPHOID | 7 | 42 | 98 |
| 361 | WOMAN | 6 | 87 | 98 |
| 362 | CD4 | 11 | 60 | 97 |
| 363 | CORD | 15 | 9 | 97 |
| 364 | MISMATCHED | 12 | 49 | 97 |
| 365 | ATRESIA | 12 | 26 | 96 |
| 366 | BIRTH | 12 | 41 | 96 |
| 367 | CONCENTRATIONS | 2 | 7 | 96 |
| 368 | PATIENT | 12 | 65 | 96 |
| 369 | KAPOSI | 1 | 7 | 95 |
| 370 | ORIGINATES | 1 | 7 | 95 |
| 371 | POST-TRANSPLANT | 1 | 7 | 95 |
| 372 | SEEDING | 1 | 7 | 95 |
| 373 | TRANSFUSED | 14 | 34 | 95 |
| 374 | ANEMIA | 4 | 5 | 94 |
| 375 | ANTIBODY | 7 | 37 | 94 |
| 376 | IMMUNODEFICIENT | 1 | 8 | 94 |
| 377 | ADVANCED | 9 | 53 | 93 |
| 378 | AMPLIFICATION | 8 | 68 | 93 |
| 379 | ANTI-CD3-IMMUNOTOXIN | 1 | 5 | 93 |
| 380 | BRAIN | 3 | 40 | 93 |
| # | Word | Recs | TLCS | TGCS |
| 381 | OPERATIONAL | 2 | 5 | 93 |
| 382 | PERITRANSPLANT | 1 | 5 | 93 |
| 383 | PRECLINICAL | 1 | 5 | 93 |
| 384 | RECIPIENT-DERIVED | 4 | 21 | 93 |
| 385 | SHORT-TERM | 3 | 37 | 93 |
| 386 | BLOCK | 5 | 59 | 92 |
| 387 | DONOR-RECIPIENT | 5 | 46 | 92 |
| 388 | OLIGOCLONAL | 1 | 8 | 92 |
| 389 | SEX-MISMATCHED | 6 | 16 | 92 |
| 390 | STRATEGY | 6 | 20 | 92 |
| 391 | BETA | 6 | 48 | 91 |
| 392 | PROTEIN-TRANSGENIC | 1 | 0 | 90 |
| 393 | RESEARCH | 1 | 0 | 90 |
| 394 | TOOL | 2 | 0 | 90 |
| 395 | XENOGRAFTS | 4 | 17 | 90 |
| 396 | ANTI-DONOR | 3 | 15 | 89 |
| 397 | COMPLEX | 5 | 50 | 89 |
| 398 | TGF-BETA | 3 | 4 | 89 |
| 399 | NON-T-CELL-DEPLETED | 11 | 50 | 88 |
| 400 | NONINVASIVE | 1 | 46 | 87 |